Candida albicans, a dimorphic fungus which normally inhabits the human gastrointestinal system, is a major cause of opportunistic fungal infection in the immunocompromised host (14) . The ability of pathogenic organisms to acquire iron in the mammalian host has been shown to be of critical importance in establishing infection (1, 15, 16, 19) . In humans, most of the iron is located intracellularly as ferritin or as heme-containing compounds. The small amount of extracellular iron is attached to the iron-binding and transport proteins transferrin and lactoferrin. Therefore, since there is essentially no free iron in the body, pathogens must acquire it from one or more iron-containing compounds (15) .
It has previously been shown by several groups that the growth of C. albicans can be inhibited in human serum (3, 6, 13, 17) . It has been further demonstrated that this growth inhibition is due to the presence of the serum protein transferrin (3, 5, 7, 13) . The expression of complement-binding mannoproteins on germ tubes, pseudohyphae, and hyphae of C. albicans but not on yeast cells has been reported. These cell surface proteins are functional homologs of the mammalian complement receptors type 2 and type 3 (2, 4, 8, 9, 12) . C. albicans can utilize these proteins to rosette complementopsonized sheep erythrocytes (SRBCs) (4, 8, 13) . We have previously shown that the binding of complement receptor type 3-like molecules to iC3b-coated SRBCs results in enhanced growth of hyphae under conditions of iron limitation (13) . We have undertaken a study to determine if C. albicans produces a hemolytic factor by which it can acquire erythrocyte-derived iron for growth.
To determine which iron-containing compounds could restore the transferrin-inhibited growth of C. albicans, ferritin, hemin, and hemoglobin (Sigma Chemical Co., St. Louis, Mo.) were added to cultures at equimolar concentrations (Fig. 1) The growth of C. albicans is dramatically inhibited in the presence of transferrin (Fig. 1) . The organism can utilize iron derived from either ferritin, hemin, or hemoglobin. However, hemoglobin-derived iron restores Candida growth more efficiently than do the other two compounds tested (Fig. 1) . The result for growth of C. albicans in RPMI 1640, a medium which contains sufficient iron to allow maximal Candida growth, is included for comparison.
Since C. albicans can utilize iron contained in hemoglobin and can rosette complement-opsonized SRBCs, a hemolysis assay was developed to determine if C. albicans produces a hemolytic factor to lyse erythrocytes. Although the presence of hemolytic activity by C. albicans has been previously reported (10, 18) A 200-,u aliquot of the diluted SRBCs was added to the Eppendorf tubes with the C. albicans. The tubes were centrifuged for 20 s to pellet the cells and then incubated at 37°C in 5% CO2 for 2 h. The pellet was resuspended by gentle pipetting and then centrifuged again. The optical density at 405 nm of 200 ,ul of the supernatant was determined with a microELISA reader. The experiment was done in triplicate, and the average optical density was used to calculate the percent hemolysis (Fig. 2) . The results indicated that C. albicans can lyse opsonized SRBCs more readily than unopsonized SRBCs and that the hyphal form shows greater hemolytic activity than does the yeast form. Cultures grown in the presence of transferrin, i.e., under conditions of iron deprivation, showed no increase in hemolytic activity. Similar levels of hemolytic activity were obtained with C. albicans Ru-7 (a gift from R. Ruchel, Hygiene Institut der Universitat, Gottingen, Germany), a strain which produces acid proteinase, and IR24 (R. Ruchel), an acid proteinase-deficient mutant (data not shown).
We have also observed that C. albicans ATCC 32354, as well as other strains and species of Candida, shows hemolytic activity when grown on enriched blood agar. Blood agar plates were prepared by adding 3 ml of washed SRBCs suspended in sterile PBS to 100 ml of agar which had been enriched with 3% glucose (wt/vol). Either Trypticase soy agar or Sabouraud dextrose agar was used. A distinct ring of lysis was observed around colonies that were incubated at 37°C in 5% CO2 for 24 to 48 h (Fig. 3) . No lysis occurred when there was no glucose in the medium or when cultures were grown at temperatures other than 37°C (data not shown).
To determine if glucose is required for the lytic effect, several different sugars were added to Trypticase soy agar and the hemolytic activity was observed. C. albicans ATCC 32354, ing sucrose, lactose, or galactose in the medium. Medium containing 2-deoxy-2-glucose inhibited the growth of the organism. The factor that is responsible for this hemolytic activity is secreted into the growth medium. Sterile filter paper disks were saturated with supernatants of overnight cultures inoculated with 2 x 108 cells per ml. A clear ring of hemolysis surrounded disks which were soaked in culture supernatants from C. albicans ATCC 32354, and the radius of this ring was comparable to that of the ring surrounding the positive control, group A streptococcus. A smaller hemolysis zone surrounded the disk containing the culture supernatant from the V6 variant and may correlate with the inability of this strain to form hyphae (Fig. 4) .
The findings presented here indicate that C. albicans has the ability to utilize iron derived from hemoglobin and that C. albicans may acquire this iron by producing a factor which can release hemoglobin by lysing erythrocytes. Production of this hemolytic factor may be regulated by the presence of glucose in the growth medium. In the present report, we define the conditions under which C. albicans can produce a hemolysin and we demonstrate that the activity is present on the intact organism and can be secreted into the culture medium. We are currently investigating the nature of this hemolytic factor in order to determine its importance as a putative virulence factor.
